François Roubille, Jean-Claude Tardif. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adenosine Monophosphate/administration & dosageAdenosine Monophosphate/analogs & derivativesAnimalsAntibodies/administration & dosageMaleMyocardial Infarction/drug therapyPlatelet Aggregation Inhibitors/administration & dosagePlatelet Membrane Glycoproteins/immunologyPurinergic P2Y Receptor Antagonists/administration & dosage
Substances: See more » AntibodiesPlatelet Aggregation InhibitorsPlatelet Membrane GlycoproteinsPurinergic P2Y Receptor Antagonistsplatelet membrane glycoprotein VIAdenosine Monophosphatecangrelor
Year: 2013 PMID: 23354515 DOI: 10.1007/s10557-013-6443-3
Source DB: PubMed Journal: Cardiovasc Drugs Ther ISSN: 0920-3206 Impact factor: 3.727